KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications
Year: 2026
Type: article
Abstract: Not available.
Source: Haematologica
Institutions: Institute of Human Genetics, Polish Academy of Sciences, Silesian University of Technology, Ghent University Hospital, Ghent University, Cancer Research Institute Ghent, Poznan University of Medical Sciences, Medical University of Lublin, Medical University of Silesia, Medical University of Lodz
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Funders: Cancer Research Institute, European Commission, Fundacja na rzecz Nauki Polskiej, Fonds Wetenschappelijk Onderzoek, Universiteit Gent, Narodowym Centrum Nauki, Śląski Uniwersytet Medyczny w Katowicach, Uniwersytet Medyczny w Lublinie, Vlaamse regering, Fondation contre le Cancer, Uniwersytet Śląski w Katowicach, Narodowe Centrum Badań i Rozwoju
Awards: G1891935821, G2677296322, G270558244, Characterizing and targeting aberrant splicing activity in acute leukemia, G4648039851, G4651203157, G4897868337, G5604943809, G5903786953, On the road to excellence in unravelling the (epi)genetic landscape of hematologic neoplasms, Personalizacja leczenia ostrej białaczki limfoblastycznej u dzieci w Polsce akronim PersonALL, Characterization and targeting of the function of the HNRNPC RNA binding protein in T-cell leukemia
OpenAlex ID: W7202342984
FWCI:
Cites:
Cited by:
Related to: